This agonistic profile of E4 on nuclear ERα activation observed in breast cancer is consistent with previous in vivo experiments performed on three recognized nuclear ERα-dependent processes showing that high doses of E4 promote uterine gene expression, endometrial proliferation and prevention of atheroma [13]. The gene discussed is ESR1; the disease is breast cancer.